ARMP - Armata Pharmaceuticals, Inc.

QQQ $ 611.13 $ 0.00 (0 %)

DIA $ 466.60 $ 0.00 (0 %)

SPY $ 670.96 $ 0.00 (0 %)

TLT $ 91.72 $ 0.00 (0 %)

GLD $ 392.00 $ 0.00 (0 %)

Previous Close

$ 3.475

Open

$ 3.40

Bid

$ 3.37 x 7

Ask

$ 3.43 x 1

Day's Range

-- - --

52 Week Range

$ 0.90 - $ 3.50

Volume

8,257

Average Volume

Market Cap

125.9M

Beta (5Y Monthly)

$ 0.75

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2025	06-30-2025	10-Q
2	05-14-2025	03-31-2025	10-Q
3	03-21-2025	12-31-2024	10-K
4	11-13-2024	09-30-2024	10-Q
5	08-13-2024	06-30-2024	10-Q
6	05-07-2024	03-31-2024	10-Q
7	03-21-2024	12-31-2023	10-K
8	08-14-2023	06-30-2023	10-Q
9	05-11-2023	03-31-2023	10-Q
10	03-16-2023	12-31-2022	10-K
11	11-09-2022	09-30-2022	10-Q
12	08-11-2022	06-30-2022	10-Q
13	05-12-2022	03-31-2022	10-Q
14	03-17-2022	12-31-2021	10-K
15	11-10-2021	09-30-2021	10-Q
16	08-12-2021	06-30-2021	10-Q
17	05-13-2021	03-31-2021	10-Q
18	03-18-2021	12-31-2020	10-K
19	11-12-2020	09-30-2020	10-Q
20	08-13-2020	06-30-2020	10-Q
21	05-14-2020	03-31-2020	10-Q
22	03-19-2020	12-31-2019	10-K
23	11-12-2019	09-30-2019	10-Q
24	08-14-2019	06-30-2019	10-Q
25	05-06-2019	03-31-2019	10-Q
26	03-25-2019	12-31-2018	10-K
27	11-08-2018	09-30-2018	10-Q
28	08-09-2018	06-30-2018	10-Q
29	05-15-2018	03-31-2018	10-Q
30	03-14-2018	12-31-2017	10-K
31	11-14-2017	09-30-2017	10-Q
32	08-14-2017	06-30-2017	10-Q
33	05-15-2017	03-31-2017	10-Q
34	03-27-2017	12-31-2016	10-K
35	11-10-2016	09-30-2016	10-Q
36	08-15-2016	06-30-2016	10-Q
37	05-12-2016	03-31-2016	10-Q
38	03-30-2016	12-31-2015	10-K
39	11-16-2015	09-30-2015	10-Q
40	08-13-2015	06-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Armata Pharmaceuticals To Present Late-Bre...
10/14/2025 11:10:32

Armata Pharmaceuticals Advances Cystic Fib...
09/08/2025 11:11:36

Armata Pharmaceuticals, Inc. (NYSE:ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company fo...

12 Health Care Stocks Moving In Wednesday'...
09/03/2025 21:06:23

Armata Pharmaceuticals Files For Mixed She...
08/13/2025 21:20:36

https://www.sec.gov/Archives/edgar/data/921114/000110465925077648/tm2523066d1_s3.htm

Armata Pharmaceuticals Q2 EPS $(0.45) Miss...
08/12/2025 20:32:36

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate o...

12 Health Care Stocks Moving In Monday's A...
05/19/2025 21:05:52

HC Wainwright & Co. Maintains Buy on Armat...
05/19/2025 17:50:05

HC Wainwright & Co. analyst Joseph Pantginis maintains Armata Pharmaceuticals (AMEX:ARMP) with a Buy and raises the pric...

12 Health Care Stocks Moving In Monday's P...
05/19/2025 12:09:34

Armata Pharmaceuticals Announced Positive ...
05/19/2025 11:04:47

Armata Pharmaceuticals Q1 EPS $(0.20) Beat...
05/14/2025 20:23:45

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of ...

Armata Secures $4.65M DoD Funding To Advan...
05/01/2025 11:46:31

Armata Pharmaceuticals Q4 2024 GAAP EPS $(...
03/20/2025 22:00:10

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of ...

Armata Enters $10M Secured Credit Agreemen...
03/12/2025 21:10:20

The gross proceeds to be received by the Company at closing are $10 million before deducting transaction-related expenses.

HC Wainwright & Co. Reiterates Buy on Arma...
12/19/2024 16:47:04

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 p...

Armata Pharmaceuticals Announced Topline R...
12/19/2024 12:19:39

Results demonstrate that inhaled AP-PA02 provides a durable reduction of Pseudomonas aeruginosa in the lung, with a favorable s...

HC Wainwright & Co. Reiterates Buy on Arma...
11/14/2024 18:16:01

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 p...

Armata Pharmaceuticals Q3 EPS $(0.15) Beat...
11/13/2024 21:31:41

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of ...

HC Wainwright & Co. Reiterates Buy on Arma...
11/12/2024 16:00:12

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 p...

Armata Pharmaceuticals Has Achieved Full E...
11/12/2024 12:14:35

Armata Pharmaceuticals Appoints David Hou...
08/15/2024 20:46:39

Armata Pharmaceuticals, Inc. (NYSE:ARMP) ("Armata" or the "Company"), a biotechnology company focused on the de...